Indication

Ovarian follicle maturation induction

Ovarian follicle maturation induction is not a distinct disease or pathology, but rather a clinical intervention and therapeutic indication within reproductive endocrinology. Read more about Ovarian follicle maturation induction

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Ovarian follicle maturation induction therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Ovarian follicle maturation induction preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ovarian follicle maturation induction.

Ovarian follicle maturation induction is not a distinct disease or pathology, but rather a clinical intervention and therapeutic indication within reproductive endocrinology.

It refers to the pharmacological stimulation of ovarian folliculogenesis and the final pre-ovulatory maturation of oocytes in females of reproductive age experiencing anovulatory infertility, oligo-ovulation, or undergoing assisted reproductive technologies.

Pathophysiologically, this intervention overcomes underlying disruptions along the hypothalamic-pituitary-ovarian axis—such as gonadotropin deficiencies or polycystic ovary syndrome—or supports controlled multi-follicular development.

The defining clinical feature is the coordinated hormonal stimulation of antral follicles to achieve graafian follicle maturity, resume oocyte meiosis, and prepare the follicles for rupture or transvaginal aspiration.

Personalize your experience

Follow Ovarian follicle maturation induction and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it